Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic breast cancer: The French experience

Seminars in Oncology

Volumn 24, Issue 1 SUPPL. 3, 1997, Pages

  Catimel, G ^a   Spielmann, M ^a   Dieras, V ^a   Tubiana Hulin, M ^a   Bonneterre, J ^a   Pouillart, P ^a   Kayitalire, L ^a   Guastalla, J P ^a   Graffand, N ^a   Garet, F ^a   Dumortier, A ^a   Pellae Cosset, B ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031047302     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)